Table 2

Associations Between Airflow Limitation According to Various Criteria and Outcomes

OutcomeNo Airflow Limitationa (n = 4,038)Airflow Limitation
FR+/LLN− (n = 297)FR+/LLN+ (n = 532)
Chronic cough1.001.40 (0.99–1.98)2.54 (2.03–3.18)
Chronic phlegm1.001.43 (0.97–2.10)3.04 (2.39–3.87)
Chronic bronchitis1.001.59 (0.93–2.72)3.14 (2.25–4.37)
Wheeze1.001.54 (1.15–2.06)3.25 (2.65–3.97)
MRC dyspnea scaleb1.001.14 (0.86–1.52)2.33 (1.92–2.82)
SF-12 Physical component scalec1.00−0.78 (.17)−3.31 (<.01)
SF-12 Mental component scalec1.000.47 (.40)−0.30 (.49)
Exacerbation1.001.33 (0.98–1.81)1.90 (1.54–2.34)
Cardiovascular disease1.001.52 (1.14–2.04)1.21 (0.93–1.56)
  • FR = fixed ratio; LLN = lower limit of normal; MRC = Medical Research Council; SF-12 = Short Form 12-item health survey.

    Notes: Multiple logistic regression analysis, except as otherwise noted. All models adjusted for age-group (<60 years), sex, and ever smoking. Data are presented as odds ratios (95% CIs) or parameter estimates (P values) from regression analysis. Number of FR−/LLN+ patients was too small for inclusion.

  • a Reference group (FR−/LLN−).

  • b Ordinal logistic regression analysis.

  • c Multiple linear regression analysis.